Through a comprehensive biocidal product review process, Noble demonstrated that the XT2 product line meets Bluesign requirements for durability, adherence, efficacy and low human toxicity, among other measures required for Bluesign certification.
“This next milestone in our partnership with Bluesign demonstrates our continued commitment to sustainability,” said Jeff Keane, chief executive officer of Noble Biomaterials. “As a leader in odor management, it’s our mission to not only deliver the performance and durability consumers expect, but also align with environmental and social impact best-practices.”
XT2 employs a proprietary process to provide permanent anti-odor protection that does not wash off or wear out. XT2 fibers are able to be dyed, providing brands with flexibility in design and the freedom to meet end-user wants and needs, the company said.
Bluesign is recognized as a benchmark in setting standards and providing third-party certification for the environmental, health and safety impacts of textile manufacturing. Noble has been a Bluesign system partner since 2013, meeting standards for production management practices in raw materials, waste water, air emissions, waste management, hazards management, safety and chemical use. Periodic audits and regular reporting of progress toward improvement goals is a key component of the Bluesign system.
Noble Biomaterials said its commitment to pursuing sustainable paths for its technologies, facilities and operations is grounded in its core values. The company works to address additional sustainability issues, including recovery and recycling of silver internally and working with several partners addressing sourcing, production and product end-of-life. In addition to its commitment to the Bluesign system, Noble produces a number of filament and fabric products that are OEKO-TEX certified, meaning they have given the organization’s stamp of approval that their textile products have been independently testing and found not to contain harmful substances.
Noble Biomaterials develops, manufactures and markets advanced technologies for consumer, medical, defense and industrial markets in the areas of bacterial management solutions and technologies that enable conductivity, odor elimination and infection prevention. It has more than 200 licensees for products in the active sports, medical, health care, industrial and consumer markets. The company’s headquarters and manufacturing facilities are in Scranton, Pa., with offices in Europe, Asia and South America.
Swiss-based Bluesign Technologies was founded in 2000 and has since been adopted by many textile manufacturers worldwide, as well as companies in the chemical and machine industries.